CUZ Q1 2026 Earnings EPS Beat Highlights Operational Resilience Tenax Therapeutics Q1 2026 Earnings Narrower Loss Surpasses Estimates Amid Pipeline Progress WEN Q1 2026 Earnings Profit Beat Lifts Shares Amid Cautious Consumer Outlook POET Q1 2026 Earnings EPS Misses Expectations as Revenue Remains Unreported Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development GitLab Q1 2026 Earnings EPS Beat Drives Stock Uptick